Pharmaceutical Compounds
from the Minds of Yale

Agent

Partner

Indication

Stage

Yale’s portfolio of vaccines and drugs in development and on the market covers many of the most challenging medical problems confronting researchers today.

NEXT PAGE

Zerit®

Bristol-Myers Squibb

AIDS

Marketed

LYMErix®

SmithKline Beecham

Lyme disease vaccine

Marketed

Promycin®

BI/Vion

Solid tumors

Phase III

GL331

GeneLabs

Gastric carcinomas

Phase II

Troxacitabine™

BioChem Pharma

Solid tumors/Leukemia

Phase II

Coviracil®

Triangle

Hepatitis B

Phase II

5G1.1-SC

Alexion

Cardiopulmonary bypass

Phase II

5FP

SuperGen

Solid tumors

Phase I

L-FMAU

Triangle

Hepatitis B

Phase I

TAPET™

Vion

Anticancer

Phase I

Triapine™

Vion

Anticancer

Phase I

bL-FD4C

Achillion

HIV and Hepatitis B

Pre-clinical

IoddU

Achillion

Epstein-Barr virus

Pre-clinical